WO2005044176A3 - Compositions containing phosphatidic acid, methods of use thereof, methods of manufacture thereof, and articles of manufacture containing same - Google Patents
Compositions containing phosphatidic acid, methods of use thereof, methods of manufacture thereof, and articles of manufacture containing same Download PDFInfo
- Publication number
- WO2005044176A3 WO2005044176A3 PCT/IL2004/001026 IL2004001026W WO2005044176A3 WO 2005044176 A3 WO2005044176 A3 WO 2005044176A3 IL 2004001026 W IL2004001026 W IL 2004001026W WO 2005044176 A3 WO2005044176 A3 WO 2005044176A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- manufacture
- phosphatidic acid
- articles
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51829603P | 2003-11-10 | 2003-11-10 | |
US60/518,296 | 2003-11-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005044176A2 WO2005044176A2 (en) | 2005-05-19 |
WO2005044176A3 true WO2005044176A3 (en) | 2005-09-09 |
Family
ID=34572990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2004/001026 WO2005044176A2 (en) | 2003-11-10 | 2004-11-10 | Compositions containing phosphatidic acid, methods of use thereof, methods of manufacture thereof, and articles of manufacture containing same |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005044176A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006011140A1 (en) * | 2004-07-27 | 2006-02-02 | Modus Biological Membranes Ltd. | Compositions and methods for smoking cessation |
IL182372A0 (en) * | 2007-04-01 | 2008-01-20 | Enzymotec Ltd | Compositions containing phosphatidylserine in treating diabetes-associated conditions |
US9101537B2 (en) | 2008-07-25 | 2015-08-11 | Reven Pharmaceuticals, Inc. | Compositions and methods for the prevention and treatment of cardiovascular diseases |
US8399432B2 (en) * | 2009-10-27 | 2013-03-19 | Lipogen Ltd. | Compositions and methods of treatment for alleviating premenstrual syndrome symptoms |
CA2806208C (en) | 2010-07-22 | 2018-02-13 | Zishan Haroon | Methods of treating or ameliorating diseases and enhancing performance comprising the use of a magnetic dipole stabilized solution |
US10869843B2 (en) | 2010-11-23 | 2020-12-22 | Chemi Nutra | Method for increasing muscle mass and strength |
MX2020005879A (en) | 2017-12-07 | 2020-10-07 | Reven Ip Holdco Llc | Compositions and methods for the treatment of metabolic conditions. |
AR120059A1 (en) * | 2019-06-12 | 2022-02-02 | Reven Ip Holdco Llc | METHODS AND COMPOSITIONS TO IMPROVE OUTCOMES OF PATIENTS WITH CANCER |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995020967A1 (en) * | 1994-02-04 | 1995-08-10 | Cell Therapeutics, Inc. | Composition for wound healing, neuron growth and vascularization |
WO1997041874A1 (en) * | 1996-05-08 | 1997-11-13 | Modus Biological Membranes Ltd. | Phosphatidic acid-comprising compositions |
US6410522B1 (en) * | 2000-10-23 | 2002-06-25 | Lipogen Ltd. | Anti-depressant, stress suppressor and mood improver |
-
2004
- 2004-11-10 WO PCT/IL2004/001026 patent/WO2005044176A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995020967A1 (en) * | 1994-02-04 | 1995-08-10 | Cell Therapeutics, Inc. | Composition for wound healing, neuron growth and vascularization |
WO1997041874A1 (en) * | 1996-05-08 | 1997-11-13 | Modus Biological Membranes Ltd. | Phosphatidic acid-comprising compositions |
US6410522B1 (en) * | 2000-10-23 | 2002-06-25 | Lipogen Ltd. | Anti-depressant, stress suppressor and mood improver |
Also Published As
Publication number | Publication date |
---|---|
WO2005044176A2 (en) | 2005-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nishi et al. | Chronic antioxidant treatment improves arterial renovascular hypertension and oxidative stress markers in the kidney in Wistar rats | |
WO2010092163A3 (en) | Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics | |
NO20054382L (en) | Diarylcycloalkyl derivatives, their preparation and their use as a drug | |
TNSN05244A1 (en) | Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter | |
MX2010001784A (en) | Novel activators of glucokinase. | |
MX349829B (en) | Infusion and injection solution of levodopa. | |
EP2594565A3 (en) | 2-acylaminopropanol-type glucosylceramide synthase inhibitors | |
WO2008083331A3 (en) | Diagnostic and therapeutic target for autoimmune diseases and uses thereof | |
WO2005012485A3 (en) | Methods for treating diabetes and related disorders using pde10a inhibitors | |
MY142830A (en) | Propionic acid derivatives useful in the treatment of lipid disorders | |
WO2002087567A3 (en) | Polymethoxylated flavones for treating insulin resistance | |
WO2006044556A3 (en) | Dual inhibitors of lipoxygenase for treating diabetes | |
WO2006055352A3 (en) | Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally | |
WO2005044176A3 (en) | Compositions containing phosphatidic acid, methods of use thereof, methods of manufacture thereof, and articles of manufacture containing same | |
WO2008058355A3 (en) | Descriptive report of patent of invention of the medicament 'atorvastatin + metformin' in combined form for cardiovascular diseases | |
Thayer et al. | Effect of angiotensin-converting enzyme insertion/deletion polymorphism DD genotype on high-frequency heart rate variability in African Americans | |
TW200500349A (en) | Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals | |
EP2219652A4 (en) | Phospholipid compositions and uses thereof | |
WO2006012438A3 (en) | Compositions and methods for treatment and prevention of insulin resistance | |
WO2007005774A3 (en) | Novel derivatives of amino acids for treatment of obesity and related disorders | |
WO2005007114A3 (en) | Method of treating diabetes type ii | |
IL175358A0 (en) | 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease | |
CN1075723C (en) | Medicine for angiocardiopathy | |
Yuksel et al. | Escitalopram intoxication | |
EP1604670A4 (en) | Supplemental food for recovery from hypoglycemic symptoms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |